Glatiramer acetate treatment does not modify the clinical course of (NZB×BXSB)F1 lupus murine model
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-10-01
著者
-
Borel Paula
Department Of Pathology And Immunology Faculty Of Medicine University Of Geneva
-
Weber Martin
Department Of Neurology University Of California
-
Santiago-raber Marie-laure
Department Of Pathology And Immunology Faculty Of Medicine University Of Geneva
-
BENKHOUCHA Mahdia
Department of Pathology and Immunology, Faculty of Medicine, University of Geneva
-
ZAMVIL Scott
Department of Neurology, University of California
-
LALIVE Patrice
Department of Pathology and Immunology, Faculty of Medicine, University of Geneva
-
Zamvil Scott
Department Of Neurology University Of California
-
Zamvil Scott
Department Of Neurology C-440 University Of California
-
Benkhoucha Mahdia
Department Of Pathology And Immunology Faculty Of Medicine University Of Geneva
-
Lalive Patrice
Department Of Pathology And Immunology Faculty Of Medicine University Of Geneva
関連論文
- Expression of aberrant forms of CD22 on B lymphocytes in Cd22^a lupus-prone mice affects ligand binding
- Glatiramer acetate treatment does not modify the clinical course of (NZB×BXSB)F1 lupus murine model
- Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production